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MARC Project 5:  
MOLECULAR EPIDEMIOLOGY OF ALCOHOLISM AND 
COMORBID DISORDERS
Richard D. Todd, Ph.D., M.D.
Blanche F. Ittleson Professor of Psychiatry
Department of Psychiatry
Washington University School of Medicine
ABSTRACT
 This MARC research project, project 5, seeks to build upon 
gene-discovery projects such as COGA (Collaborative Study 
on the Genetics of Alcoholism: PIs Begleiter and Reich) and 
similar projects (e.g. PIs Hill, Kendler) which are studying 
treatment-ascertained alcoholics and their relatives, and the 
MARC-affiliated Alcohol-QTL IRPG consortium (PIs Heath, 
Martin, Madden, Todd), which is studying community-
ascertained alcoholics and heavy smokers and their adult 
relatives, by incorporating a molecular genetic component 
into 4 mature, prospective longitudinal studies (PIs Chassin, 
Cooper, Heath, Sher) spanning the age-range from early 
adolescence into young adulthood, with 3-7 waves of 
prospective assessment.  
ABSTRACT (continued)
 In addition to collecting DNA from the target samples (years 1-3), 
this research project will combine secondary data-analysis and 
genotyping, proceeding in 4 stages: (i) longitudinal and other 
phenotypic analyses to establish consistent phenotype 
definition across informative data-sets (not all data-sets will be 
informative for all phenotypes of interest) (years 1-3); (ii) 
behavioral genetic analyses using existing twin data sets 
(MOAFTS, the former MARC Project 1, or other U.S. and 
Australian data-sets to which we have access through the 
MARC) to confirm heritability of phenotypes defined at stage (i), 
and where possible determine whether that phenotypic 
operationalization is optimal for understanding genetic effects 
(which may not be the case if the structures of genetic and 
environmental influences are very different) (years 1-3); (iii) 
genotyping for a limited number of candidate genes (years 3-5); 
and (iv) genetic association analysis (years 4-5). 
ABSTRACT (continued)
 This carefully staged approach is necessary to minimize the 
dangers of multiple testing when combining candidate gene 
data and rich longitudinal data sets. For the same reason, we 
focus on a limited number of candidate phenotypes where 
prospective data are expected to be informative for 
understanding the etiology of alcoholism, as justified under 
Background and Preliminary studies.  Selection of candidate 
phenotypes and candidate genes is guided by the MARC 
focus on the roles of overlapping mechanisms of behavioral 
under control, negative affect regulation and pharmacologic 
vulnerability in the etiology of alcohol use disorders (AUDs), 
emphasizing AUD phenotypes associated with (a) 
externalizing symptoms, (b) tolerance and quantitative 
consumption indices, (c) cognitive aspects of alcohol use 
(expectancies), (d) co-occurrence with tobacco dependence, 
and (e) negative affect (depression, suicidality).
Specific Aims
 Project Goals
• 1.1. To obtain blood samples for DNA extraction, from 
participants in 4 prospective longitudinal studies (PI-s 
Chassin, Cooper, Heath, Sher).
• 1.2. To derive phenotypes of alcohol involvement (use and 
problems) and co-occurring features based on longitudinal 
course, that can be operationalized across two or more data-
sets, focused on four domains: (i) externalizing symptoms; 
(ii) consumption, as well as cognitive aspects of alcohol use 
(expectancies); (iii) co-occurrence with tobacco dependence; 
(iv) co-occurrence with early trauma and depression, from 
the databases of these 4 studies.  Two approaches will be 
emphasized for phenotype identification – developmental 
(e.g. using mixture modeling to identify trajectories through 
time); and state/trait modeling (e.g. modeling chronicity of 
effects).
Specific Aims
 Project Goals (continued)
• 1.3. To conduct secondary analyses of existing twin and 
children-of-twins data sets to confirm heritability of the 
variables thus defined, excluding non-genetic phenotypes 
from further analysis, and further refining phenotypes 
where necessary.
• 1.4. Following these two stages of secondary data-
analysis, to test for candidate gene effects on these 
phenotypes (however, choice of candidate gene is 
expected to need revision in the light of emerging findings 
from ongoing gene-discovery efforts, including MARC-
affiliated projects, by the time the genotyping phase of the 
project begins):
Specific Aims
 Project Goals (continued)
• 1.4 
 (i) AUDs and externalizing symptoms (DRD4, DRD5, 
SLC6A3 (DAT1 in old notation));
 (ii) AUDs, alcohol consumption and alcohol 
expectancies (ALDH2 promoter polymorphism, ADH1B 
(ADH2 in old notation), ADH1C (ADH3 in old notation);
 (iii) AUDs and tobacco consumption (CHRNA4, 
CHRNA7, CHRNB2);
 (iv) AUDs and early trauma and other high-risk 
environmental exposures associated with parental 
alcoholism (CRF, NPY, SLC6A4 (HTT in old notation)).
Specific Aims
 Project Goals (continued)
• 1.5 Through the availability of DNA from the participants 
in these longitudinal studies, to encourage future 
coordinated genotyping efforts by the principal 
investigators of the original studies, beyond the 5-year 
funding period of this center project, to take full 
advantage of the information about alcoholism etiology 
that has been gathered in these studies.
Preliminary Results
 Our efforts over the 1st year have been devoted to 
organization of d data sets and analytic approaches for the 
determination of phenotypes of interests for genetic analysis 
and the completion of an initial screening project to 
determine interest of subjects participating in this project.  
Current progress for this study has occurred on two fronts.
 First, three meetings of key investigators and biostatisticians 
have been held over the last year to discuss analytic 
approaches to the development of phenotypes across data 
sets and to begin joining data sets.  The consensus is that 
phenotypes will be initially developed in the two University of 
Missouri data sets then tested for heritability in the MOAFTS 
(Missouri Adolescent Female Twin Study) data set.  Common 
items and constructs are being developed.
Preliminary Results (continued)
 Second, a test of how to approach subjects for blood 
collection is underway in the Sher et al. study. At the time of 
our first progress report, 257 individuals (approximately ½ of 
the target sample) had been contacted to assess interest in 
the study, and 249 agreed to participate (a 96.9% initial 
cooperation rate). Materials for blood collection are being 
mailed to potential participants. The participants are asked to 
go to local clinics or laboratories for blood drawing and 
samples are then express shipped to the laboratory at 
Washington University.  The next wave of interviews with the 
MOAFTS sample has begun, and blood collection efforts with 
cooperative twins is being conducted with these.
 Progress to Date on Sample Collection and 
Genotyping
• Blood and buccal swab samples are now being 
collected for DNA isolation from all four 
prospective studies populations.
• To date a total of 1,332 specimens have been 
received in the lab. Of these, DNA has been 
prepared and under gone quality control checks 
for 1,102 individuals.  Functional repeat 
polymorphism genotypes have been produced 
for DRD4, DRD5 , SLC6A3 (DAT1) and SLC6A4 
(HHT) loci on 971 samples.
Preliminary Results (continued)
 Immediate Plans
• During the next year we anticipate completing 
sample collection, repeat polymorphism 
genotyping and most single nucleotide 
polymorphism (snp) genotyping as well as 
developing phenotypes for joint samples.
Preliminary Results (continued)
